Several studies reported that tumor-promoting miRNAs targeting PTEN are involved in drug resistance9,38–40 and that their multiple inhibition by a long non-coding RNA-mediated strategy induced sorafenib sensitization in HCC41. The gene discussed is PTEN; the disease is neoplasm.